glaumax 20 mg/ml + 5 mg/ml kapi za oko, otopina
jadran galenski laboratorij d.d., svilno 20, rijeka - dorzolamidklorid timololmaleat - kapi za oko, otopina - 20 mg/ml + 5 mg/ml - urbroj: 1 ml otopine sadrži 20 mg dorzolamida u obliku dorzolamidklorida i 5 mg timolola u obliku timololmaleata
sufentanil altamedics 5 mikrograma/ml otopina za injekciju/infuziju
altamedics d.o.o., vrbani 4, zagreb, hrvatska - sufentanilcitrat - otopina za injekciju / infuziju - 5 mikrograma/ml - urbroj: 1 ml otopine za injekciju/infuziju sadrži 5 mikrograma sufentanila u obliku suflentanilcitrata
ge healthcare lunar-dpx, prodigy i idxa
medicom d.o.o., zagreb - stolni denzitometar, uređaj za mjerenje udjela koštane srži
navien a+intracranial catheter
cardio medical zagreb d.o.o. utinjska 40 10000 zagreb -
tears naturale kapi za oko, otopina
alcon farmaceutika d.o.o., avenija dubrovnik 16, zagreb - dextranum, hypromellosum - kapi za oko, otopina - 1 mg/ml + 3 mg/ml - urbroj: 1 ml otopine sadrži 1 mg dekstrana 70 i 3 mg hipromeloze
optimmun
intervet international b.v., podružnica u republici hrvatskoj, ivana lučića 2a, 10000 zagreb, hrvatska - ciklosporin a - mast za oko - osjetila, pripravci za liječenje bolesti oka (oftalmici), ostali očni pripravci - pasa
dropcys
lucane pharma - mercaptamine - corneal diseases; cystinosis - liječenje rožnice naslage cistin,.
stromease 25 mg/ml
domes pharma, 3 rue andré citroën, 63430 pont-du-château, francuska - acetilcistein - kapi za oko, otopina za pse i mačke - pasa i mačaka
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemorrhagics - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - uterusa - hipofiza i hipotalamusni hormoni i analozi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.